Dirk Vogelgesang
University of Greifswald
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dirk Vogelgesang.
Catheterization and Cardiovascular Interventions | 2002
Johannes B. Dahm; Dirk Vogelgesang; Astrid Hummel; Alexander Staudt; Henry Völzke; Stephan B. Felix
Transradial coronary interventions (TCI) are occasionally limited by radial spasms and postprocedural radial occlusions, which are related to the radial diameter and which possibly may be reduced by the use of smaller guiding catheter. However, 5 Fr, 0.058″ lumen diameter guiding catheter affords less strength, visibility, and backup. In a randomized study, we investigated procedural and clinical success and vascular access complications of 5 Fr in comparison to 6 Fr guiding catheter. One hundred seventy‐one patients with coronary lesions suitable for at least 5 Fr transradial approach (i.e., normal Allen test, only balloon angioplasty and stent) were randomly assigned for 5 or 6 Fr TCI. The primary combined endpoint was procedural and clinical success, and secondary endpoints were vascular access complications and the occurrence of postprocedural radial occlusions at 1‐month follow‐up. Procedural success was achieved in 95.4% of 5 Fr and 92.9% of 6 Fr patients. Selective cannulation of the coronary ostium failed in 1.1% of 5 Fr and 4.8% of 6 Fr patients (P = 0.08). Minor hematomas without need for surgical repair or blood transfusions occurred in 1.1% (5 Fr) and 4.8% (6 Fr; P = 0.07); 1.1% of 5 Fr and 5.9% of 6 Fr patients (P = 0.05) suffered loss of radial pulse due to radial occlusion. Selected noncomplex coronary lesions can successfully and safely be treated either with 5 or 6 Fr guiding catheters. A tendency of higher procedural success rates and lower vascular access complications was documented after 5 Fr in comparison to 6 Fr TCI. This was particularly the case among patients with small radial diameters. Cathet Cardiovasc Intervent 2002;57:172–176.
Stroke | 2004
Birger Wolff; Henry Völzke; Jan Lüdemann; Daniel M. Robinson; Dirk Vogelgesang; Alexander Staudt; Christof Kessler; Johannes B. Dahm; Ulrich John; Stephan B. Felix
Background and Purpose— Several studies have provided evidence for a relationship between body iron load and cardiovascular disease. We analyzed the association of serum ferritin levels with carotid atherosclerosis. Methods— We assessed intima-media thickness and plaque prevalence in the carotid arteries by high-resolution ultrasound among 2443 participants (1200 women; age, 45 to 79 years) in the Study of Health in Pomerania (SHIP), a population-based study in northeast Germany. Results— In multivariate analysis, serum ferritin levels were not independently associated with carotid intima-media thickness among women or men. In contrast, the relationship between serum ferritin levels and carotid plaque prevalence was significant among men (odds ratio per 1-SD increase of serum ferritin levels, 1.33; 95% confidence interval, 1.08 to 1.44) yet not among women (odds ratio, 1.29; 95% confidence interval, 0.98 to 1.75). However, both men and women showed a dose-response relation between serum ferritin levels and carotid atherosclerosis in which higher serum ferritin levels were associated with greater odds ratios for carotid plaque prevalence. Additionally, there was an interaction of serum ferritin levels with low-density lipoprotein (LDL) cholesterol (P =0.039) among men in which the association of serum ferritin levels with carotid plaque prevalence became stronger with increasing LDL cholesterol levels. Conclusions— Our study identified a relationship between serum ferritin levels and carotid atherosclerosis that was potentiated by LDL cholesterol. This relationship adds support to the hypothesis of a link between iron and cardiovascular disease.
American Journal of Cardiology | 2002
Johannes B. Dahm; Eberhard Kuon; Dirk Vogelgesang; Astrid Hummel; Bernhard Möx; Alexander Staudt; Stephan B. Felix
precludes a precise estimate of coronary disease, the increased prevalence of traditional risk factors (e.g., smoking, hypertension, diabetes) among the cases compared with the controls is consistent with the presence of underlying coronary atherosclerosis in a signifi cant proportion of the sudden death cases. Because of the community-based nature of the study, paramedics were able to obtain blood specimens only from patients for whom an intravenous line was placed as part of provision of emergency medical care once the patient was clinically stable or resuscitation had proved ineffective. Thus, the circumstances of the cardiac arrest or the provision of medical care often precluded the blood draw, and specimens for genotyping were available from only a fraction (25%) of all sudden deaths that occurred during the study period, which may introduce some bias. However, the characteristics of study participants with and without blood drawn were similar among cases as well as controls. Although medical history data were collected through spousal interviews and not fully validated by medical record review, a small validation study demonstrated that spouses accurately provide
Heart | 2006
Johannes B. Dahm; Joerg Ruppert; Stefanie Hartmann; Dirk Vogelgesang; Astrid Hummel; Stephan B. Felix
Objectives: To examine by retrospective analysis of data from the FLEXI-CUT monocentre registry whether atherectomy can effectively simplify complex stent implantation in ostial bifurcation lesions by reducing the procedure to stenting of the left anterior descending (LAD) or left circumflex (LCX) artery ostium alone. Patients and methods: All patients who had been enrolled in the prospective FLEXI-CUT study (directional atherectomy with adjunctive balloon angioplasty) were retrospectively analysed on the basis of significant LAD or LCX ostial stenosis (⩾ 70% stenosis) deriving from an undiseased left main stem. The primary combined end point was the rate of target lesion revascularisation (TLR) and binary restenosis; secondary end points were procedural success and major adverse cardiac events (MACE) at the six-month follow up. Results: Of 30 patients enrolled with significant LAD or LCX ostium stenosis, 29 were effectively treated with directional atherectomy (96.7% procedural success). All patients underwent single-vessel stenting procedures of solely the LAD or LCX ostium. At follow up, binary stenosis was 25% (6 of 24), TLR (angiographic plus clinical) 10.3% (3 of 29) and total MACE 6.9% (2 of 29). Conclusions: Directional atherectomy with single-vessel stenting procedures facilitates the interventional treatment of LAD and LCX ostium stenosis, and leads to remarkably low TLR and binary stenosis at follow up.
Vascular Health and Risk Management | 2008
Dirk Vogelgesang; Johannes B. Dahm; Holm Großmann; Andre Hippe; Astrid Hummel; Christian Lotze; Silke Vogelgesang
Primary malignant cardiac tumors (cardiac angiosarcomas) are exceedingly rare. Since there are initially nonspecific or missing symptoms, these tumors are usually diagnosed only in an advanced, often incurable stage, after the large tumor mass elicits hemodynamic obstructive symptoms. A 59-year-old female presented with symptoms of cerebral ischemia. A computed tomography (CT) scan showed changes suggestive of stroke. Transesophageal echocardiography revealed an inhomogeneous, medium-echogenic, floating mass at the roof of the left atrium near the mouth of the right upper pulmonary vein, indicative of a thrombus. At surgery, a solitary tumor was completely enucleated. Histologically, cardiac angiosarcoma was diagnosed. The patient received adjuvant chemotherapy and was free of symptoms and recurrence of disease at 14 months follow-up. Due to the fortuitous appearance of clinical signs indicative of stroke, cardiac angiosarcoma was diagnosed and effectively treated at an early, nonmetastatic, and therefore potentially curable stage. Although cardiac angiosarcoma is a rare disease, it should be taken into consideration as a potential cause of cerebral embolic disease.
Atherosclerosis | 2007
Martin Landsberger; Birger Wolff; Franziska Jantzen; Christian Rosenstengel; Dirk Vogelgesang; Alexander Staudt; Johannes B. Dahm; Stephan B. Felix
International Journal of Cardiology | 2007
Marcus Dörr; Dirk Vogelgesang; Astrid Hummel; Alexander Staudt; Daniel M. Robinson; Stephan B. Felix; Johannes B. Dahm
International Journal of Cardiology | 2007
Henry Völzke; Julia Henzler; Dirk Menzel; Daniel M. Robinson; Wolfgang Hoffmann; Dirk Vogelgesang; Ulrich John; Wolfgang Motz; Rainer Rettig
Endocrine Journal | 2006
Henry Völzke; Sybille Gruska; Dirk Vogelgesang; Wolfgang Kerner; Günter Kraatz; Rainer Rettig
Europace | 2007
Dirk Vogelgesang; Silke Vogelgesang